Now, there is some evidence that "If the immune system of a blood recipient isn't strong enough to neutralize spike protein, blood clots and amyloid aggregates may also form."
Japanese researchers warn of the risks of using blood from mRNA COVID vaccine recipients, highlighting potential deadly effects and the need for urgent action to secure the global blood supply.
The researchers advocate for comprehensive testing of both jabbed and unjabbed individuals to assess the safety of blood products and suggest discarding blood products contaminated with spike proteins or modified mRNA until effective removal methods have been developed.
In a recent meta-analysis1,2 posted on preprints.org, Japanese researchers warn of potentially deadly risks to patients who receive blood from people who have taken mRNA COVID jabs and call for urgent action to ensure the safety of the global blood supply.
Public confidence - Public awareness of these potential risks, even if they are theoretical or have a very low likelihood of occurring, could affect individuals' willingness to donate or receive blood transfusions, thereby lowering blood donation rates and the overall trust in the safety of blood transfusions.
Formation of blood clots and amyloid aggregates - If the immune system of a blood recipient isn't strong enough to neutralize spike protein, blood clots and amyloid aggregates may also form.
In any case, these cohort studies are expected to help establish cutoff values for blood levels of spike protein and other substances to determine the safety of blood products.
No comments:
Post a Comment